In the calcaneus cancer pain model, Wacnik et al [22] found that TNF-α was released at the tumor site and systemic pre-implantation as well as local post-implantation injection of the soluble receptor antagonist TNFR:Fc could partially block ongoing tumor-associated mechanical hyperalgesia. The gene discussed is TNF; the disease is cancer.